IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 413

India’s cumulative vaccination coverage crosses 178.52 Crore. More than 21 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 178.52 Crore (1,78,52,44,126) today. More than 21 lakh (21,70,356) Vaccine Doses have been administered till 7 pm today. More than 2.04 Crore (2,04,78,473) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10401948
2nd Dose 9973419
Precaution Dose 4227886
FLWs 1st Dose 18410162
2nd Dose 17454977
Precaution Dose 6331547
Age Group 15-18 years 1st Dose 55252106
  2nd Dose 30085582
Age Group 18-44 years 1st Dose 552349062
2nd Dose 448197759
Age Group 45-59 years 1st Dose 202360562
2nd Dose 181047657
Over 60 years 1st Dose 126481828
2nd Dose 112750591
Precaution Dose 9919040
Cumulative 1st dose administered 965255668
Cumulative 2nd dose administered 799509985
Precaution Dose 20478473
Total 1785244126

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 4th March, 2022 (413rd Day)
HCWs 1st Dose 85
2nd Dose 1426
Precaution Dose 12875
FLWs 1st Dose 99
2nd Dose 2779
Precaution Dose 17848
Age Group 15-18 years 1st Dose 97972
  2nd Dose 603714
Age Group 18-44 years 1st Dose 114974
2nd Dose 894729
Age Group 45-59 years 1st Dose 18058
2nd Dose 197668
Over 60 years 1st Dose 13344
2nd Dose 122288
Precaution Dose 72497
Cumulative 1st dose administered 244532
Cumulative 2nd dose administered 1822604
Precaution Dose 103220
Total 2170356

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker